1.
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiov...
by Danesh, J
European journal of epidemiology, 2007-12-01, Vol.22 (12), p.839-869
2.
Serum Uric Acid Independently Predicts Cardiovascular Events in Advanced Nephropathy
by Kanbay, Mehmet
American journal of nephrology, 2012-10, Vol.36 (4), p.324-331
3.
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
by Mihaylova, B
The Lancet (British edition), 2012, Vol.380 (9841), p.581-590
4.
Racial (Black–White) Divergence in the Association Between Adiponectin and Arterial Stiffness in Asymptomatic Young Adults: The Bogalusa Heart Study
by Nguyen, Quoc M.
American journal of hypertension, 2008-05, Vol.21 (5), p.553-557
5.
Amino-Terminal Pro-B-Type Natriuretic Peptide Improves Discrimination for Incident Atherosclerotic Cardiovascular Disease Beyond Ambulatory Blood Pressure in Elderly Men
by Skoglund, Per H
Hypertension (Dallas, Tex. 1979), 2015-09, Vol.66 (3), p.681-686
6.
Low plasma levels of adiponectin are associated with low risk for future cardiovascular events in patients with clinical evident vascular disease
by Hajer, Gideon R., MD
The American heart journal, 2007, Vol.154 (4), p.750.e1-750.e7
7.
Rationale and design of the Further cardiovascular OUtcomes Research with PCSK9 Inhibition in subjects with Elevated Risk trial
by Sabatine, Marc S., MD, MPH
The American heart journal, 2015, Vol.173, p.94-101
8.
The role of uric acid in the pathogenesis of human cardiovascular disease
by Kanbay, Mehmet
Heart, 2013-06, Vol.99 (11), p.759-766
9.
Sex differences in cardiovascular ageing
by Merz, Allison A
Heart, 2016-06, Vol.102 (11), p.825-831
10.
Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease
by Lees, Jennifer S
Nature medicine, 2019-11, Vol.25 (11), p.1753-1760
11.
Adipocyte fatty acid binding protein: a novel adipokine involved in the pathogenesis of metabolic and vascular disease?
by Kralisch, S
Diabetologia, 2012-09-29, Vol.56 (1), p.10-21
12.
Predictors of Hyperkalemia and Death in Patients With Cardiac and Renal Disease
by Jain, Nishank, MD, MPH
The American journal of cardiology, 2012, Vol.109 (10), p.1510-1513
13.
Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease
by Myasoedova, Elena
Annals of the rheumatic diseases, 2011-03, Vol.70 (3), p.482-487
14.
Efficacy and Safety of Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Statin-Treated Patients With Persistent High Triglycerides (from the ANCHOR Study)
by Ballantyne, Christie M., MD
The American journal of cardiology, 2012, Vol.110 (7), p.984-992
15.
Pathophysiology of diabetic dyslipidaemia: where are we?
by Verges, Bruno
Diabetologia, 2015-03-01, Vol.58 (5), p.886-899
16.
Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials
by Stettler, Christoph
The American heart journal, 2006, Vol.152 (1), p.27-38
17.
The Nonskeletal Effects of Vitamin D: An Endocrine Society Scientific Statement
by Rosen, Clifford J
Endocrine reviews, 2012-06, Vol.33 (3), p.456-492
18.
Associations of objectively measured sedentary behaviour and physical activity with markers of cardiometabolic health
by Henson, J
Diabetologia, 2013-03-01, Vol.56 (5), p.1012-1020
19.
Fibroblast Growth Factor 23 and Cause-Specific Mortality in the General Population: The Northern Manhattan Study
by Souma, Nao
The journal of clinical endocrinology and metabolism, 2016-10, Vol.101 (10), p.3779-3786
20.
Coconut oil consumption and cardiovascular risk factors in humans
by Eyres, Laurence
Nutrition reviews, 2016-04, Vol.74 (4), p.267-280
